Natixis Advisors LLC Purchases 1,648 Shares of Embecta Corp. (NASDAQ:EMBC)

Natixis Advisors LLC increased its position in shares of Embecta Corp. (NASDAQ:EMBC) by 5.7% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 30,735 shares of the company’s stock after purchasing an additional 1,648 shares during the period. Natixis Advisors LLC owned about 0.05% of Embecta worth $433,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of the stock. Copeland Capital Management LLC bought a new stake in shares of Embecta during the third quarter worth $43,000. Iat Reinsurance Co. LTD. bought a new stake in shares of Embecta during the second quarter worth $50,000. CWM LLC grew its holdings in shares of Embecta by 773.8% during the second quarter. CWM LLC now owns 9,079 shares of the company’s stock worth $113,000 after purchasing an additional 8,040 shares during the last quarter. Canada Pension Plan Investment Board bought a new stake in shares of Embecta during the second quarter worth $140,000. Finally, Cardinal Capital Management lifted its stake in shares of Embecta by 16.8% during the second quarter. Cardinal Capital Management now owns 11,753 shares of the company’s stock valued at $147,000 after acquiring an additional 1,691 shares during the period. 93.83% of the stock is currently owned by institutional investors.

Embecta Price Performance

Shares of Embecta stock opened at $20.59 on Friday. Embecta Corp. has a 1 year low of $9.93 and a 1 year high of $20.80. The business has a 50-day moving average of $14.48 and a two-hundred day moving average of $14.11. The company has a market capitalization of $1.19 billion, a P/E ratio of 17.16 and a beta of 0.97.

Embecta Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 18th. Investors of record on Friday, December 6th will be issued a dividend of $0.15 per share. The ex-dividend date of this dividend is Friday, December 6th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 2.91%. Embecta’s payout ratio is presently 50.00%.

Wall Street Analysts Forecast Growth

Separately, BTIG Research raised Embecta from a “neutral” rating to a “buy” rating and set a $26.00 target price on the stock in a research note on Wednesday.

About Embecta

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes.